Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Feder

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Journal of Substance Use and Addiction Treatment|October 23, 2024
Client and program-level factors associated with planned use of medications for opioid use disorder in specialty substance use treatment programs: Evidence from linked administrative data and survey dataKenneth A Feder, Yuzhong Li, Kathryn N Burke, et al.
Journal of Child & Adolescent Substance Abuse|April 19, 2021
Association of Mental Health Symptoms and Peer Behaviors with Risk for Substance Use and Condomless Sex among Youth in Juvenile Drug CourtKenneth A Feder, Michael R McCart, Geoffrey Kahn, et al.
Journal of Substance Use and Addiction Treatment|May 1, 2025
Use of harm reduction practices by state-licensed specialty substance use treatment programsIsha K Desai, Kathryn Burke, Yuzhong Li, et al.
Journal of Substance Use and Addiction Treatment|March 18, 2024
Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadershipKathryn N Burke, Noa Krawczyk, Yuzhong Li, et al.
Drug and Alcohol Dependence|September 16, 2023
Trends in self-reported non-fatal overdose and patterns of substance use before and during the COVID-19 pandemic in a prospective cohort of adults who have injected drugs - Baltimore, Maryland, 2014-2022Kenneth A Feder, Eshan U Patel, Megan Buresh, et al.
Addictive Behaviors|November 7, 2025
Medication for opioid use disorder among adolescents entering specialty treatment for opioid use disorder and trends in the US, 2017-2022Jesse S Boggis, Thadryan Sweeney, Lisa A Marsch, et al.
Journal of Substance Use and Addiction Treatment|April 29, 2025
Integration of harm reduction principles and practices within specialty substance use treatment programs in New Jersey: A qualitative study of program leadershipValerie S Ganetsky, Kenneth A Feder, Kathryn N Burke, et al.
The Journal of Infectious Diseases|December 10, 2024
Impact of Pandemic-Induced Service Disruptions and Behavioral Changes on Hepatitis C Virus and HIV Transmission Amongst People Who Inject Drugs: A Modeling StudyJasmine Wang, Becky L Genberg, Kenneth A Feder, et al.
Drug and Alcohol Dependence|August 22, 2017
Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care ActKenneth A Feder, Ramin Mojtabai, Noa Krawczyk, et al.
Public Health Reports (Washington, D.C. : 1974)|July 18, 2022
COVID-19 Vaccine Hesitancy and Vaccination Status in a Community-Based Cohort of People Who Inject Drugs in Baltimore, Maryland, March-June 2021Javier A Cepeda, Kenneth A Feder, Jacqueline Astemborski, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Journal of Substance Use and Addiction Treatment|October 23, 2024
Client and program-level factors associated with planned use of medications for opioid use disorder in specialty substance use treatment programs: Evidence from linked administrative data and survey dataKenneth A Feder, Yuzhong Li, Kathryn N Burke, et al.
Journal of Child & Adolescent Substance Abuse|April 19, 2021
Association of Mental Health Symptoms and Peer Behaviors with Risk for Substance Use and Condomless Sex among Youth in Juvenile Drug CourtKenneth A Feder, Michael R McCart, Geoffrey Kahn, et al.
Journal of Substance Use and Addiction Treatment|May 1, 2025
Use of harm reduction practices by state-licensed specialty substance use treatment programsIsha K Desai, Kathryn Burke, Yuzhong Li, et al.
Journal of Substance Use and Addiction Treatment|March 18, 2024
Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadershipKathryn N Burke, Noa Krawczyk, Yuzhong Li, et al.
Drug and Alcohol Dependence|September 16, 2023
Trends in self-reported non-fatal overdose and patterns of substance use before and during the COVID-19 pandemic in a prospective cohort of adults who have injected drugs - Baltimore, Maryland, 2014-2022Kenneth A Feder, Eshan U Patel, Megan Buresh, et al.
Addictive Behaviors|November 7, 2025
Medication for opioid use disorder among adolescents entering specialty treatment for opioid use disorder and trends in the US, 2017-2022Jesse S Boggis, Thadryan Sweeney, Lisa A Marsch, et al.
Journal of Substance Use and Addiction Treatment|April 29, 2025
Integration of harm reduction principles and practices within specialty substance use treatment programs in New Jersey: A qualitative study of program leadershipValerie S Ganetsky, Kenneth A Feder, Kathryn N Burke, et al.
The Journal of Infectious Diseases|December 10, 2024
Impact of Pandemic-Induced Service Disruptions and Behavioral Changes on Hepatitis C Virus and HIV Transmission Amongst People Who Inject Drugs: A Modeling StudyJasmine Wang, Becky L Genberg, Kenneth A Feder, et al.
Drug and Alcohol Dependence|August 22, 2017
Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care ActKenneth A Feder, Ramin Mojtabai, Noa Krawczyk, et al.
Public Health Reports (Washington, D.C. : 1974)|July 18, 2022
COVID-19 Vaccine Hesitancy and Vaccination Status in a Community-Based Cohort of People Who Inject Drugs in Baltimore, Maryland, March-June 2021Javier A Cepeda, Kenneth A Feder, Jacqueline Astemborski, et al.
Pageof 9